A detailed history of Aqr Capital Management LLC transactions in Tyra Biosciences, Inc. stock. As of the latest transaction made, Aqr Capital Management LLC holds 28,069 shares of TYRA stock, worth $436,192. This represents 0.0% of its overall portfolio holdings.

Number of Shares
28,069
Previous 28,712 2.24%
Holding current value
$436,192
Previous $274,000 43.07%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

SELL
$9.59 - $13.99 $6,166 - $8,995
-643 Reduced 2.24%
28,069 $392,000
Q2 2025

Aug 14, 2025

BUY
$7.06 - $10.86 $202,706 - $311,812
28,712 New
28,712 $274,000

Others Institutions Holding TYRA

About Tyra Biosciences, Inc.


  • Ticker TYRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,973,600
  • Market Cap $652M
  • Description
  • Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...
More about TYRA
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.